Literature DB >> 15448103

Melanocortin 4 receptor gene variation is associated with severe obesity in Pima Indians.

Lijun Ma1, P Antonio Tataranni, Clifton Bogardus, Leslie J Baier.   

Abstract

Heterozygous coding mutations in the melanocortin 4 receptor gene (MC4R) are the most common genetic causes of severe human obesity identified to date. To determine whether MC4R has a role in causing severe obesity in Pima Indians, we sequenced the coding region of this gene in 426 full-heritage, non-first-degree related, adult Pima Indians (300 severely obese and 126 nondiabetic nonobese control subjects). Three coding variations were detected as heterozygotes only in severely obese subjects. One variation, detected in three obese subjects, was a novel single-base insertion (A) at nucleotide 100, and it predicted a frameshift and premature STOP at codon 37. The second variant, detected in 10 obese subjects, predicted a previously identified arginine-to-glutamine substitution at codon 165, and the third variant, detected in one obese subject, predicted a novel glycine-to-serine substitution at codon 231. Three polymorphisms were also identified in the 5' untranslated region, but these variants were detected in both obese and lean subjects and had similar allele frequencies. We conclude that variations in MC4R may account for a small portion of obesity in Pima Indians, but they do not explain the overall high prevalence of obesity in this Native American population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448103     DOI: 10.2337/diabetes.53.10.2696

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

Review 1.  From obesity genetics to the future of personalized obesity therapy.

Authors:  Julia S El-Sayed Moustafa; Philippe Froguel
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

2.  Several mutations in the melanocortin 4 receptor gene are associated with obesity in Chinese children and adolescents.

Authors:  C L Wang; L Liang; H J Wang; J F Fu; J Hebebrand; A Hinney
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

3.  Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.

Authors:  Zhimin Xiang; Bettina Proneth; Marvin L Dirain; Sally A Litherland; Carrie Haskell-Luevano
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

4.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

5.  Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice.

Authors:  James L Smart; Virginie Tolle; Malcolm J Low
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

6.  Evaluation of A2BP1 as an obesity gene.

Authors:  Lijun Ma; Robert L Hanson; Michael T Traurig; Yunhua L Muller; Bakhshish P Kaur; Jessica M Perez; David Meyre; Mao Fu; Antje Körner; Paul W Franks; Wieland Kiess; Sayuko Kobes; William C Knowler; Peter Kovacs; Philippe Froguel; Alan R Shuldiner; Clifton Bogardus; Leslie J Baier
Journal:  Diabetes       Date:  2010-08-19       Impact factor: 9.461

7.  Association of functionally significant Melanocortin-4 but not Melanocortin-3 receptor mutations with severe adult obesity in a large North American case-control study.

Authors:  Melissa A Calton; Baran A Ersoy; Sumei Zhang; John P Kane; Mary J Malloy; Clive R Pullinger; Yana Bromberg; Len A Pennacchio; Robert Dent; Ruth McPherson; Nadav Ahituv; Christian Vaisse
Journal:  Hum Mol Genet       Date:  2008-12-17       Impact factor: 6.150

8.  Hypothalamic and hindbrain melanocortin receptors contribute to the feeding, thermogenic, and cardiovascular action of melanocortins.

Authors:  Karolina P Skibicka; Harvey J Grill
Journal:  Endocrinology       Date:  2009-10-23       Impact factor: 4.736

9.  The impact of genetic variants on BMI increase during childhood versus adulthood.

Authors:  M G Hohenadel; L J Baier; P Piaggi; Y L Muller; R L Hanson; J Krakoff; M S Thearle
Journal:  Int J Obes (Lond)       Date:  2016-04-14       Impact factor: 5.551

10.  Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice.

Authors:  E Csongradi; J M Docarmo; J H Dubinion; T Vera; D E Stec
Journal:  Int J Obes (Lond)       Date:  2011-04-05       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.